SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
SPRC stock price ended at $0.68 on Salı, after rising 0.00%
On the latest trading day Feb 10, 2026, the stock price of SPRC rose by 0.00%, climbing from $0.66 to $0.68. During the session, the stock saw a volatility of 7.81%, with prices oscillating between a daily low of $0.64 and a high of $0.69. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 94.7K shares were traded, equating to a market value of approximately $2.2M.
SPRCTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 3
Nötr Sinyaller 0
Satış Sinyalleri 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
SPRC, şu anda 3 alım sinyali ve 4 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam -- fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
SPRC için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek SPRC için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.